vs
Side-by-side financial comparison of Crexendo, Inc. (CXDO) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
Crexendo, Inc. is the larger business by last-quarter revenue ($18.1M vs $12.6M, roughly 1.4× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 6.7%, a 243.9% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 11.2%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 12.4%).
Crexendo, Inc. is a U.S.-headquartered cloud communications technology provider. It delivers unified communications as a service (UCaaS), contact center solutions, business VoIP services, and collaborative work tools, primarily catering to small and medium-sized enterprises operating in the North American market.
CXDO vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.1M | $12.6M |
| Net Profit | $1.2M | $31.5M |
| Gross Margin | — | — |
| Operating Margin | 6.3% | — |
| Net Margin | 6.7% | 250.7% |
| Revenue YoY | 11.2% | 24080.8% |
| Net Profit YoY | 140.2% | 250.9% |
| EPS (diluted) | $0.03 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.1M | $12.6M | ||
| Q3 25 | $17.5M | $0 | ||
| Q2 25 | $16.6M | $0 | ||
| Q1 25 | $16.1M | $12.0K | ||
| Q4 24 | $16.2M | $52.0K | ||
| Q3 24 | $15.6M | $65.0K | ||
| Q2 24 | $14.7M | $114.0K | ||
| Q1 24 | $14.3M | $140.0K |
| Q4 25 | $1.2M | $31.5M | ||
| Q3 25 | $1.4M | $-7.4M | ||
| Q2 25 | $1.2M | $-1.7M | ||
| Q1 25 | $1.2M | $-13.9M | ||
| Q4 24 | $507.0K | — | ||
| Q3 24 | $148.0K | $-17.1M | ||
| Q2 24 | $588.0K | $-17.9M | ||
| Q1 24 | $434.0K | $-12.7M |
| Q4 25 | 6.3% | — | ||
| Q3 25 | 7.5% | — | ||
| Q2 25 | 6.7% | — | ||
| Q1 25 | 7.2% | -122758.3% | ||
| Q4 24 | 3.9% | — | ||
| Q3 24 | 0.9% | -28604.6% | ||
| Q2 24 | 3.9% | -16720.2% | ||
| Q1 24 | 3.4% | -9987.1% |
| Q4 25 | 6.7% | 250.7% | ||
| Q3 25 | 8.3% | — | ||
| Q2 25 | 7.4% | — | ||
| Q1 25 | 7.3% | -115550.0% | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 0.9% | -26380.0% | ||
| Q2 24 | 4.0% | -15668.4% | ||
| Q1 24 | 3.0% | -9049.3% |
| Q4 25 | $0.03 | $0.56 | ||
| Q3 25 | $0.05 | $-0.13 | ||
| Q2 25 | $0.04 | $-0.03 | ||
| Q1 25 | $0.04 | $-0.25 | ||
| Q4 24 | $0.03 | — | ||
| Q3 24 | $0.00 | $-0.32 | ||
| Q2 24 | $0.02 | $-0.33 | ||
| Q1 24 | $0.01 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $40.3M |
| Total DebtLower is stronger | $114.0K | — |
| Stockholders' EquityBook value | $63.8M | $59.0M |
| Total Assets | $77.7M | $68.9M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $40.3M | ||
| Q3 25 | — | $48.6M | ||
| Q2 25 | — | $31.2M | ||
| Q1 25 | — | $48.9M | ||
| Q4 24 | — | $52.9M | ||
| Q3 24 | — | $76.3M | ||
| Q2 24 | — | $63.5M | ||
| Q1 24 | — | $82.3M |
| Q4 25 | $114.0K | — | ||
| Q3 25 | $236.0K | — | ||
| Q2 25 | $356.0K | — | ||
| Q1 25 | $475.0K | — | ||
| Q4 24 | $592.0K | — | ||
| Q3 24 | $709.0K | — | ||
| Q2 24 | $823.0K | — | ||
| Q1 24 | $937.0K | — |
| Q4 25 | $63.8M | $59.0M | ||
| Q3 25 | $61.3M | $26.5M | ||
| Q2 25 | $58.3M | $32.8M | ||
| Q1 25 | $55.2M | $33.8M | ||
| Q4 24 | $51.4M | $46.1M | ||
| Q3 24 | $49.5M | $65.5M | ||
| Q2 24 | $48.2M | $80.5M | ||
| Q1 24 | $46.8M | $96.2M |
| Q4 25 | $77.7M | $68.9M | ||
| Q3 25 | $76.0M | $54.2M | ||
| Q2 25 | $71.4M | $62.1M | ||
| Q1 25 | $67.4M | $77.7M | ||
| Q4 24 | $64.9M | $110.5M | ||
| Q3 24 | $62.3M | $135.2M | ||
| Q2 24 | $59.6M | $149.9M | ||
| Q1 24 | $57.5M | $167.7M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $-8.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 1.93× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | $-8.4M | ||
| Q3 25 | $4.4M | $17.4M | ||
| Q2 25 | $1.3M | $-17.7M | ||
| Q1 25 | $1.2M | $-4.0M | ||
| Q4 24 | $2.2M | $-23.4M | ||
| Q3 24 | $1.6M | $12.8M | ||
| Q2 24 | $2.7M | $-18.7M | ||
| Q1 24 | $-166.0K | $5.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $1.3M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 7.7% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | 1.93× | -0.26× | ||
| Q3 25 | 3.05× | — | ||
| Q2 25 | 1.05× | — | ||
| Q1 25 | 1.06× | — | ||
| Q4 24 | 4.29× | — | ||
| Q3 24 | 10.95× | — | ||
| Q2 24 | 4.51× | — | ||
| Q1 24 | -0.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CXDO
| Services | $8.6M | 48% |
| Software Solution Segment | $8.3M | 46% |
| Products | $1.1M | 6% |
SPRO
Segment breakdown not available.
